Clinical Trials on FXR in Norway
Total 11 results
-
Oslo University HospitalVestre Viken Hospital Trust; Helse Stavanger HF; Haukeland University Hospital; Sorlandet Hospital HF and other collaboratorsCompletedDelivery Complication | Induced; Birth | Indications for Care in Pregnancy; Labor; and DeliveryNorway
-
University of TromsoUniversity Hospital of North NorwayCompletedHealth Services for the Aged | Medication Therapy ManagementNorway
-
University of BergenNORCE Norwegian Research Centre AS; Bergen MunicipalityActive, not recruitingAlzheimer Disease | Mild Cognitive Impairment | MCI With Increased Risk for Alzheimer DiseaseNorway
-
Rene KahnCompletedUltra High Risk for PsychosisSpain, Austria, Germany, Israel, Italy, Netherlands, Norway, Switzerland, United Kingdom
-
National Development and Research Institutes, Inc.National Institute on Drug Abuse (NIDA); University of California, Los Angeles and other collaboratorsCompletedComputer-assisted, Evidence-based Psychosocial Intervention | for Substance Abuse TreatmentUnited States
-
AmgenCompletedTreatment for Prevention of Chronic MigraineUnited States, United Kingdom, Poland, Germany, Czechia, Sweden, Canada, Denmark, Finland, Norway
-
AmgenCompletedTreatment for Prevention of Chronic MigraineUnited States, United Kingdom, Poland, Germany, Czechia, Sweden, Canada, Denmark, Finland, Norway
-
AstraZenecaThe Cleveland Clinic; IQVIA RDS Inc.CompletedEligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)United States, Belgium, Italy, Netherlands, Denmark, Taiwan, Poland, Russian Federation, Korea, Republic of, Hungary, United Kingdom, China, New Zealand, Czechia, Australia, South Africa, Ukraine, Japan, Canada, Mexico, Lithuania, Estoni...
-
Novo Nordisk A/SCompletedChronic Kidney Disease | Turner Syndrome | Noonan Syndrome | Chronic Renal Insufficiency | Growth Hormone Disorder | Growth Hormone Deficiency in Children | Adult Growth Hormone Deficiency | Genetic Disorder | Foetal Growth Problem | Small for Gestational AgeIsrael, Saudi Arabia, Spain, Argentina, Russian Federation, Germany, Netherlands, Italy, Belgium, United Kingdom, Slovenia, Ireland, Sweden, Denmark, Hungary, Finland, Norway, France, Czechia, Lithuania, Luxembourg, Serbia, Switzerland
-
AstraZenecaBristol-Myers Squibb; Hadassah Medical Organization; The TIMI Study GroupCompletedDiabetes Mellitus, Non-Insulin-Dependent | High Risk for Cardiovascular EventUnited States, Canada, France, Italy, Netherlands, Spain, Belgium, Thailand, Vietnam, Bulgaria, Korea, Republic of, Brazil, Philippines, Russian Federation, Turkey, Taiwan, Australia, Israel, South Africa, Germany, Japan, Czechia, H... and more